• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Oxford University

AstraZeneca vaccine recipients in U.K. will wait up to 12 weeks for second dose

December 31, 2020 By Brian Buntz

An inexpensive COVID-19 vaccine from AstraZeneca (LON:AZN) — now authorized in the U.K. — could go on to become the most widely used in the world. It is inexpensive and easy to produce.  But a major hurdle that could slow its rollout in the U.K. after yesterday’s approval is the question of how to best […]

Filed Under: Featured, Pharmaceutical, Regulatory/Compliance Tagged With: AstraZeneca plc, coronavirus, COVID-19, COVID-19 vaccine, Medicines and Healthcare Products Regulatory Agency, Oxford University, United Kingdom

BREAKING: AstraZeneca says its COVID-19 vaccine could be up to 90% effective

November 23, 2020 By Sean Whooley

AstraZeneca (NYSE:AZN) announced today that one of its COVID-19 vaccine candidate dosing regimens is 90% effective in preventing the virus. Cambridge, United Kingdom-based AstraZeneca, working in collaboration with Oxford University, found the vaccine to be highly effective in preventing COVID-19 for subjects in the UK and Brazil, with no hospitalizations or severe cases of the disease […]

Filed Under: Clinical Trials, Featured, Pharmaceutical, Research & Development Tagged With: AstraZeneca plc, coronavirus, COVID-19, Oxford University

MedTech 100 roundup: Stocks show no signs of slowing down

November 9, 2020 By Sean Whooley

The medtech industry hit further highs in the market last week and the stocks show no sign of stopping their ascent now. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 97.62 (Nov. 6), marking a 7.3% leap from the 91.01 points registered at the […]

Filed Under: Business/Financial News, Diagnostics, Featured, Funding Roundup, Genomics/Molecular Diagnostics, MassDevice Earnings Roundup, Mergers & Acquisitions, Pharmaceutical, Research & Development, Wall Street Beat Tagged With: BioNTech, coronavirus, COVID-19, Hologic, Inspire Medical Systems Inc., Livongo, MedTech 100 Index, Mesa Biotech, NovoCure, Oxford University, Pfizer, Stryker, Teladoc, transmedics

Report: Oxford chief says there’s ‘small chance’ COVID-19 vaccine is ready by Christmas

November 4, 2020 By Sean Whooley

The director of the group developing a COVID-19 vaccine candidate at Oxford University says it’s possible that the vaccine could be ready by Christmas. According to a Reuters report, Oxford vaccine trial chief investigator Andrew Pollard said he’s optimistic that the university, which is collaborating with AstraZeneca on the vaccine, will present trial results by the end […]

Filed Under: Business/Financial News, Clinical Trials, Featured, Pharmaceutical, Research & Development Tagged With: AstraZeneca plc, coronavirus, COVID-19, Oxford University

Report: AstraZeneca Phase III COVID-19 vaccine remains on hold in U.S.

September 24, 2020 By Sean Whooley

AstraZeneca (NYSE:AZN) is reportedly keeping its COVID-19 vaccine trial in the U.S. on hold as questions remain over patient safety. U.S. Health and Human Services Dept. Secretary Alex Azar told CNBC yesterday that federal investigators are looking for “answers to important questions,” regarding the safety of patients involved in the trial operated by the United Kingdom-based company in […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Pharmaceutical Tagged With: AstraZeneca plc, coronavirus, COVID-19, Dept. of Health & Human Services (HHS), Donald Trump, Oxford University

AstraZeneca puts COVID-19 vaccine trial on hold

September 9, 2020 By Sean Whooley

AstraZeneca (NYSE:AZN) announced today that it voluntarily paused the trials for its COVID-19 vaccine candidate after an unexplained illness. The company said in a news release that a standard review process was triggered so an independent committee could review safety data surrounding a single event of an unexplained illness that occurred in the UK Phase III […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Pharmaceutical Tagged With: AstraZeneca plc, coronavirus, COVID-19, Oxford University

Oxford researchers report positive early trial results for COVID-19 vaccine candidate

July 20, 2020 By Sean Whooley

Researchers at Oxford University say early-stage results from a Phase I/II clinical trial of a SARS-CoV-2 vaccine candidate display safety and strong immune responses. Results, published in The Lancet, revealed that the vaccine is safe, causes few side effects and induces strong immune responses in both parts of the immune system in the fight against COVID-19, […]

Filed Under: Business/Financial News, Featured, Pharmaceutical, Research & Development Tagged With: BioNTech, coronavirus, COVID-19, Oxford University, Pfizer

Oxford researchers find widely available steroid reduces COVID-19 deaths

June 16, 2020 By Sean Whooley

Oxford researchers announced today that, following testing with thousands of patients, dexamethasone may improve patient survival in cases of COVID-19. Dexamethasone is a corticosteroid commonly used for treating arthritis and other cases of inflammation. In total, 2,104 patients were randomized in Oxford’s trial to receive dexamethasone in doses of 6 mg, once per day, either […]

Filed Under: Featured, Food & Drug Administration (FDA), Pharmaceutical, Regulatory/Compliance, Research & Development Tagged With: coronavirus, COVID-19, FDA, Oxford University

Amputees’ brain remember missing limbs even years later

September 14, 2016 By Sarah Faulkner

Researchers from Oxford University demonstrated that amputees’ brains can remember their missing hands, even 30 years later. At Oxford University’s Hand & Brain Lab, the researchers used an ultra-high-power MRI scanner to monitor the brain activity of 2 people who lost their left hands 25 to 30 years ago. The scientists also scanned the brains […]

Filed Under: Prosthetics, Research & Development Tagged With: Oxford University

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS